Year archive

AIM Vaccine Co., Ltd. — 2024 filings

All 72 regulatory filings released by AIM Vaccine Co., Ltd. (6660) in 2024, sourced directly from the official regulator.

72 Filings

2024 Period

2024 filings (72)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - SECOND GENERATION OF HIGHLY-EFFECTIVE ABSORBED TETANUS VACCINE OBTAINED THE CLINICAL TRIAL APPROVAL Regulatory Filings	2024-12-19	English
VOLUNTARY ANNOUNCEMENT - SUSPENSION CULTURE INFLUENZA VACCINE (MDCK CELLS) WITH NEW TECHNOLOGICAL ROUTE OBTAINED THE CLINICAL TRIAL APPROVAL Regulatory Filings	2024-12-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-02	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2024-11-25	English
VOLUNTARY ANNOUNCEMENT - ANNOUNCEMENT ON THE 2024 CORPORATE DAY EVENT Investor Presentation	2024-11-25	English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF THE PRE-APPLICATION FOR MARKETING REGISTRATION OF THE ITERATIVE SERUM-FREE RABIES VACCINE Regulatory Filings	2024-11-17	English
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL OF THE ITERATIVE-PROCESS HIGHLY-EFFECTIVE HUMAN DIPLOID RABIES VACCINE Regulatory Filings	2024-11-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-04	English
VOLUNTARY ANNOUNCEMENT - 13-VALENT PNEUMONIA CONJUGATE VACCINE: PHASE III CLINICAL TRIALS COMPLETED, PRODUCTION LICENSE OBTAINED AND APPLICATION FOR DRUG MARKETING REGISTRATION DULY SUBMITTED Regulatory Filings	2024-10-31	English
VOLUNTARY ANNOUNCEMENT - MRNA RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE OBTAINED THE CLINICAL TRIAL APPROVAL Regulatory Filings	2024-10-29	English
VOLUNTARY ANNOUNCEMENT - UNBLINDING OF DATA FROM PHASE III CLINICAL TRIAL OF ITERATIVE SERUM-FREE RABIES VACCINE: PRE-DEFINED CLINICAL OBJECTIVES MET WITH GOOD IMMUNOGENICITY AND SAFETY Regulatory Filings	2024-10-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-03	English
2024 INTERIM REPORT Interim / Quarterly Report	2024-08-29	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report	2024-08-29	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2024-08-29	English
RE-DESIGNATION OF DIRECTORS Board/Management Information	2024-08-29	English
VOLUNTARY ANNOUNCEMENT - OFFICIAL APPLICATION FOR CLINICAL TRIALS FOR QUADRIVALENT INFLUENZA VIRUS VACCINE (MDCK CELLS) SUBMITTED Regulatory Filings	2024-08-29	English
VOLUNTARY ANNOUNCEMENT - OFFICIAL APPLICATION FOR CLINICAL TRIALS FOR ABSORBED TETANUS VACCINE SUBMITTED Regulatory Filings	2024-08-29	English
VOLUNTARY ANNOUNCEMENT - PRE-APPLICATIONS FOR CLINICAL TRIALS FOR MRNA RSV AND MRNA SHINGLES/HERPES ZOSTER VACCINES OF AIM VACCINE SUBMITTED TO FDA Regulatory Filings	2024-08-29	English
NOTICE OF BOARD MEETING Report Publication Announcement	2024-08-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-02	English
VOLUNTARY ANNOUNCEMENT - PRE-APPLICATIONS FOR CLINICAL TRIALS FOR TWO MRNA VACCINES OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND SHINGLES/HERPES ZOSTER OF AIM VACCINE SUBMITTED Regulatory Filings	2024-06-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Share Issue/Capital Change	2024-06-04	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 20, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-05-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Share Issue/Capital Change	2024-05-07	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-05-07	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-05-07	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-05-07	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-05-07	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Share Issue/Capital Change	2024-05-07	English
FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 20, 2024 AGM Information	2024-04-25	English
NOTICE OF 2023 ANNUAL GENERAL MEETING AGM Information	2024-04-25	English
CIRCULAR OF 2023 ANNUAL GENERAL MEETING AGM Information	2024-04-25	English
2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Environmental & Social Information	2024-04-25	English
2023 ANNUAL REPORT Annual Report	2024-04-25	English
Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors Remuneration Information	2024-04-19	English
VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER Major Shareholding Notification	2024-04-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-03	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-04-03	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-04-03	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-04-03	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2024-04-03	English
VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE SUBMIT Regulatory Filings	2024-03-28	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Annual Report	2024-03-28	English
VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR QUADRIVALENT INFLUENZA VIRUS VACCINE (MDCK CELLS) SUBMITTED Regulatory Filings	2024-03-28	English
VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR NOVEL-PROCESS HIGHLY-EFFECTIVE HUMAN DIPLOID RABIES VACCINE SUBMITTED Regulatory Filings	2024-03-26	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-03-15	English
VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR CLINICAL TRIALS FOR ABSORBED TETANUS VACCINE SUBMITTED Regulatory Filings	2024-03-04	English
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE II CLINICAL TRIAL OF TETRAVALENT MENINGOCOCCAL CONJUGATE VACCINE Regulatory Filings	2024-03-04	English
PROFIT WARNING Regulatory Filings	2024-03-04	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE LAYOUT OF ITERATIVE RABIES VACCINE PRODUCTS AND FULLY ADVANCING THE RESEARCH AND DEVELOPMENT OF THE PRODUCT SERIES Regulatory Filings	2024-03-04	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE LAYOUT OF ITERATIVE PNEUMONIA VACCINE PRODUCTS AND FULLY ADVANCING THE RESEARCH AND DEVELOPMENT OF THE PRODUCT SERIES Regulatory Filings	2024-03-04	English
VOLUNTARY ANNOUNCEMENT - EXPECTED COMPLETION OF APPLICATION FOR MARKETING OF 13-VALENT PNEUMONIA CONJUGATE VACCINE, ITERATIVE SERUM-FREE RABIES VACCINE AND 23-VALENT PNEUMONIA POLYSACCHARIDE VACCINE I Regulatory Filings	2024-03-04	English
VOLUNTARY ANNOUNCEMENT - PRE-APPLICATION FOR MARKETING REGISTRATION FOR 13-VALENT PNEUMONIA CONJUGATE VACCINE SUBMITTED Regulatory Filings	2024-03-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-01	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2024-02-29	English
Articles of Association Governance Information	2024-02-29	English
(1) POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON FEBRUARY 29, 2024; (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (3) APPOINTMENTS OF THE EXECUTIVE VICE-CHAIRMAN Declaration of Voting Results & Voting Rights Announcements	2024-02-29	English
(1) Notification Letter to Non-registered Shareholder and (2) Updated Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-08	English
FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON FEBRUARY 29, 2024 Proxy Solicitation & Information Statement	2024-02-08	English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-02-08	English
NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING AGM Information	2024-02-08	English
(1) ELECTION OF THE EXECUTIVE VICE-CHAIRMAN AND THE VICE-CHAIRMAN OF THE BOARD; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION Board/Management Information	2024-02-08	English
CLOSURE OF REGISTER OF MEMBERS Regulatory Filings	2024-02-07	English
Arrangement of Electronic Dissemination of Corporate Communications Report Publication Announcement	2024-02-01	English
New Arrangements on Dissemination of Corporate Communications Regulatory Filings	2024-02-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-01	English
VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER Major Shareholding Notification	2024-01-09	English
VOLUNTARY ANNOUNCEMENT - FURTHER CONTINUOUS INCREASE IN SHAREHOLDING OF H SHARES BY THE CONTROLLING SHAREHOLDER Major Shareholding Notification	2024-01-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Share Issue/Capital Change	2024-01-02	English